Estrella Immunopharma, Inc.
- ESLA
- NASDAQ
- Biotechnology
- Cell Therapy (T-cell)
- Oncology
$0.34
Today −22.02%Quote Oct 19, 2026, 02:34 PM UTC
−18.25%over the last month
Max drawdown −40.6%From 1-month high −19.7%3 months −47.9%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$14.6M
Quote Oct 19
Next earnings
Dec 2
Expected, not confirmed
Latest analyst target
—
Data unavailable
Floor
$0.33
3.0% below price
Where the price sits
No analyst target range for this stock.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about ESLAPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
No revenue split by segment on file.
Industry
Biotechnology
Employees
3